Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Peretz

Showing results (81-90 of 110) with videos related to

Pageof 11
Sort By:
Harefuah|May 15, 1996
[Prognostic factors in breast cancer patients]I Roisman, T Peretz, A Z Reznick, et al.
Thrombosis and Haemostasis|July 1, 1995
Control of cell proliferation by heparan sulfate and heparin-binding growth factorsI Vlodavsky, H Q Miao, R Atzmon, et al.
Gynecologic Oncology|June 12, 2003
Population attributes affecting the prevalence of BRCA mutation carriers in epithelial ovarian cancer cases in israelG Hirsh-Yechezkel, A Chetrit, F Lubin, et al.
European Journal of Cancer & Clinical Oncology|December 1, 1989
Systemic administration of doxorubicin-containing liposomes in cancer patients: a phase I studyA Gabizon, T Peretz, A Sulkes, et al.
Clinical and Experimental Immunology|July 28, 2015
Messenger RNA encoding constitutively active Toll-like receptor 4 enhances effector functions of human T cellsA Pato, G Eisenberg, A Machlenkin, et al.
British Journal of Cancer|May 13, 2004
A single-nucleotide polymorphism in the RAD51 gene modifies breast cancer risk in BRCA2 carriers, but not in BRCA1 carriers or noncarriersL Kadouri, Z Kote-Jarai, A Hubert, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|July 31, 1999
Genetic testing of breast and ovarian cancer patients: clinical characteristics and hormonal risk modifiersL Kaduri, M Gibs, A Hubert, et al.
International Journal of Radiation Oncology, Biology, Physics|November 1, 1989
Treatment of primary unresectable carcinoma of the pancreas with I-125 implantationT Peretz, D Nori, B Hilaris, et al.
Israel Journal of Medical Sciences|September 1, 1988
Treatment of primary and metastatic liver cancer using an implantable chemoinfusion pumpT Peretz, H R Freund, R Isacson, et al.
Journal of Mammary Gland Biology and Neoplasia|September 8, 2001
Molecular properties and involvement of heparanase in cancer progression and mammary gland morphogenesisE Zcharia, S Metzger, T Chajek-Shaul, et al.
Pageof 11

Showing results (81-90 of 110) with videos related to

Sort By:
Pageof 11
Harefuah|May 15, 1996
[Prognostic factors in breast cancer patients]I Roisman, T Peretz, A Z Reznick, et al.
Thrombosis and Haemostasis|July 1, 1995
Control of cell proliferation by heparan sulfate and heparin-binding growth factorsI Vlodavsky, H Q Miao, R Atzmon, et al.
Gynecologic Oncology|June 12, 2003
Population attributes affecting the prevalence of BRCA mutation carriers in epithelial ovarian cancer cases in israelG Hirsh-Yechezkel, A Chetrit, F Lubin, et al.
European Journal of Cancer & Clinical Oncology|December 1, 1989
Systemic administration of doxorubicin-containing liposomes in cancer patients: a phase I studyA Gabizon, T Peretz, A Sulkes, et al.
Clinical and Experimental Immunology|July 28, 2015
Messenger RNA encoding constitutively active Toll-like receptor 4 enhances effector functions of human T cellsA Pato, G Eisenberg, A Machlenkin, et al.
British Journal of Cancer|May 13, 2004
A single-nucleotide polymorphism in the RAD51 gene modifies breast cancer risk in BRCA2 carriers, but not in BRCA1 carriers or noncarriersL Kadouri, Z Kote-Jarai, A Hubert, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|July 31, 1999
Genetic testing of breast and ovarian cancer patients: clinical characteristics and hormonal risk modifiersL Kaduri, M Gibs, A Hubert, et al.
International Journal of Radiation Oncology, Biology, Physics|November 1, 1989
Treatment of primary unresectable carcinoma of the pancreas with I-125 implantationT Peretz, D Nori, B Hilaris, et al.
Israel Journal of Medical Sciences|September 1, 1988
Treatment of primary and metastatic liver cancer using an implantable chemoinfusion pumpT Peretz, H R Freund, R Isacson, et al.
Journal of Mammary Gland Biology and Neoplasia|September 8, 2001
Molecular properties and involvement of heparanase in cancer progression and mammary gland morphogenesisE Zcharia, S Metzger, T Chajek-Shaul, et al.
Pageof 11